YieldMax MSTR Option Income Strategy ETF vs 22nd Century Group Inc — how do they compare? YieldMax MSTR Option Income Strategy ETF trades at $12.35, while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). Which is the better fit depends on your goals.
| MSTY | XXII | |
|---|---|---|
Sector | Income / Options Overlay | Technology |
52-Week High | $95.95 | $801.00 |
52-Week Low | $11.55 | $3.72 |
Market Cap | — | $1.52M |
Enterprise Value | — | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
MSTY trades at $12.27, down 2.23% for the day amid a bearish technical signal. The ETF has faced significant price erosion, with recent articles highlighting substantial capital losses despite high distribution yields. Key support and resistance levels are tightly clustered around $12-13, indicating limited near-term price movement. No fundamental financial ratios are available, as the ETF's structure focuses on option income rather than traditional corporate earnings.
The outlook remains highly risky due to structural flaws in the fund's distribution model, which can return investor capital as income. Media sentiment is overwhelmingly negative, citing uncapped losses and tax inefficiencies. Investors should prioritize understanding the ETF's strategy and inherent risks over yield chasing.
XXII trades at $4.38, up 0.69% with neutral technical signals. The company shows concerning fundamentals with negative profit margins (-65.76% net income margin) and ROE of -130.19%, though valuation ratios appear low (P/S 0.03, P/B 0.07). Recent corporate actions include a 20:1 reverse stock split in June 2026. Analyst sentiment remains positive with 75% buy ratings, while the company expands VLN® product distribution in key markets like California and New York.
The outlook remains speculative given persistent losses despite revenue generation. Investment opportunity lies in successful execution of reduced-nicotine cigarette expansion and FDA regulatory progress. Key risks include continued cash burn, competitive pressures, and dependency on regulatory approvals for growth catalysts.
Trailing returns across standard periods
MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on MSTY →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →